No Picture
News

Center for Beta Cell Therapy in Diabetes and ViaCyte Announce Start of European Clinical Trial of Human Stem Cell-derived Implants in Type 1 Diabetes Patients

BRUSSELS and SAN DIEGO, Jan. 21, 2019 /PRNewswire/ — The Center for Beta Cell Therapy in Diabetes, coordinator of an international consortium in translational medicine in diabetes, and ViaCyte, Inc., a privately held regenerative medicine company,… […]

No Picture
News

Applied Spectral Imaging (ASI) reveals advanced FISH solutions that deliver ultra-fast imaging analysis

CARLSBAD, Calif., Jan. 16, 2019 /PRNewswire/ — Applied Spectral Imaging (ASI), a global leader and provider of biomedical imaging analysis solutions has launched a new product update to facilitate the growing demands of pathology and cytogenetic la… […]

No Picture
News

Neurotech Pharmaceuticals, Inc. and Lowy Medical Research Institute Announce Publication of NT-501 Phase 2 Results

CUMBERLAND, R.I. and LA JOLLA, Calif., Jan. 16, 2019 /PRNewswire/ — The results of the NT-501 Phase 2 study sponsored by Neurotech Pharmaceuticals, Inc. (Neurotech) in collaboration with the Lowy Medical Research Institute (LMRI), have been publish… […]

No Picture
News

Phoenix Molecular Designs Announces Collaboration To Develop Diagnostic for Triple-Negative Breast Cancer

-Diagnostic can detect activated RSK2, a prime target in TNBC, in breast cancer patients-

VANCOUVER, British Columbia and SAN DIEGO, Jan. 16, 2019 /PRNewswire/ — Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing… […]

No Picture
News

Mirati Therapeutics Announces Dosing Of First Patient In Phase 1/2 Clinical Trial Of MRTX849, A Novel KRAS G12C Inhibitor

SAN DIEGO, Jan. 15, 2019 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, announced today that it has dosed the first patient in a Phase 1/2 clinical trial of MRTX849, an investigational KRAS G12C… […]

No Picture
News

Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2018 Financial Results

Conference Call and Webcast Scheduled for Tuesday, February 5

SAN DIEGO, Jan. 15, 2019 /PRNewswire/ — Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it will report fourth quarter and year-end 2018 financial results after the Nasdaq… […]

No Picture
News

GenScript Launches Novel Technology Licensed from Amgen for Accelerating Protein and Antibody Purification

AmMag SA magnetic purification system first to offer high throughput of large samples, accelerating early stage drug development

SAN DIEGO, Jan. 14, 2019 /PRNewswire/ — GenScript®, the world’s leading gene synthesis provider, announced today at PepT… […]